文献速递浆细胞疾病

多发性骨髓瘤完整lncRNA转录组特征揭示其功能与临床影响

Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma.
PubMed 文献 · Leukemia · 2021-02-17

本研究在多发性骨髓瘤(MM)样本中鉴定出40,511个新lncRNA,lncRNA占MM转录组的82%且表达异质性高于编码基因。与正常骨髓浆细胞相比,鉴定出10,351个过表达和9,535个下调lncRNA,其中989个lncRNA在MM中独有表达,89个显示表观基因组从头激活。敲低SMILO可抑制MM细胞增殖、诱导凋亡并激活干扰素通路,lncRNA表达联合临床与遗传风险可分层患者的无进展生存和总生存。

要点

  • lncRNA占MM转录组82%,表达异质性高于编码基因。
  • 鉴定989个MM独有表达lncRNA,89个表观基因组从头激活。
  • 敲低SMILO抑制增殖、诱导凋亡并激活干扰素通路。

核心结论

  • MM中lncRNA转录组高度异质,特定lncRNA与疾病生物学和临床行为相关。

研究设计与样本

  • 基于MM样本的lncRNA转录组分析,鉴定40,511个新lncRNA。
  • 比较MM患者与正常骨髓浆细胞lncRNA表达差异。
  • 结合正常B细胞成熟过程分析lncRNA转录动态。
  • 对SMILO进行敲低功能研究。
  • 分析lncRNA表达联合临床与遗传风险对生存的影响。

主要发现

  • lncRNA占MM转录组的82%,表达异质性高于编码基因。
  • MM患者中10,351个lncRNA过表达、9,535个下调。
  • 989个lncRNA在MM中独有表达,其中89个表观基因组从头激活。
  • 敲低SMILO导致MM细胞增殖减少、凋亡诱导和干扰素通路激活。
  • lncRNA表达联合临床与遗传风险将患者分层为不同无进展生存和总生存组。

临床怎么用

  • lncRNA表达谱联合临床与遗传风险可用于MM患者生存分层。
  • SMILO等特定lncRNA可能作为MM治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) is an incurable disease, whose clinical heterogeneity makes its management challenging, highlighting the need for biological features to guide improved therapies. Deregulation of specific long non-coding RNAs (lncRNAs) has been shown in MM, nevertheless, the complete lncRNA transcriptome has not yet been elucidated. In this work, we identified 40,511 novel lncRNAs in MM samples. lncRNAs accounted for 82% of the MM transcriptome and were more heterogeneously expressed than coding genes. A total of 10,351 overexpressed and 9,535 downregulated lncRNAs were identified in MM patients when compared with normal bone-marrow plasma cells. Transcriptional dynamics study of lncRNAs in the context of normal B-cell maturation revealed 989 lncRNAs with exclusive expression in MM, among which 89 showed de novo epigenomic activation. Knockdown studies on one of these lncRNAs, SMILO (specific myeloma intergenic long non-coding RNA), resulted in reduced proliferation and induction of apoptosis of MM cells, and activation of the interferon pathway. We also showed that the expression of lncRNAs, together with clinical and genetic risk alterations, stratified MM patients into several progression-free survival and overall survival groups. In summary, our global analysis of the lncRNAs transcriptome reveals the presence of specific lncRNAs associated with the biological and clinical behavior of the disease.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Carrasco-Leon A, Ezponda T, Meydan C, et al. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia. 2021. PMID: 33597729. doi:10.1038/s41375-021-01147-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。